ArticleExperimental and therapeutic medicine2021

Tat-thioredoxin 1 reduces inflammation by inhibiting pro-inflammatory cytokines and modulating MAPK signaling.

Eun Ji Yeo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.